_id
691726653c536f8df2316b65
Ticker
UPB
Name
Upstream Bio, Inc.
Exchange
NASDAQ
Address
890 Winter Street, Waltham, MA, United States, 02451
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://upstreambio.com
Description
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Last Close
25.93
Volume
452806
Current Price
31.02
Change
-0.26
Last Updated
2026-01-07T13:54:01.999Z
Image
https://logo.clearbit.com/upstreambio.com
Ipo Date
2024-10-11T00:00:00.000Z
Market Cap
1261260800
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.47
Sentiment Sources
1
Rating
4.5
Target Price
49.75
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
683000
Cost Of Revenue
31000
Gross Profit
652000
Operating Expenses
38486000
Operating Income
-37834000
Interest Expense
-
Pretax Income
-33748000
Net Income
-33748000
Eps
-0.6257631750053114
Dividends Per Share
-
Shares Outstanding
54038591
Income Tax Expense
-
EBITDA
-33717000
Operating Margin
-5539.385065885798
Total Other Income Expense Net
4086000
Cash
72164000
Short Term Investments
300263000
Receivables
683000
Inventories
-
Total Current Assets
389017000
Property Plant Equipment
1984000
Total Assets
391195000
Payables
3952000
Short Term Debt
716000
Long Term Debt
-
Total Liabilities
12611000
Equity
378584000
Bs_currency_symbol
USD
Depreciation
-2828000
Change In Working Capital
16037000
Cash From Operations
-22240000
Capital Expenditures
47000
Cash From Investing
48186000
Cash From Financing
760000
Net Change In Cash
26706000
Cf_currency_symbol
USD
PE
-
PB
4.418934621959724
ROE
-8.914270016693786
ROA
-8.62689962806273
FCF
-22287000
Fcf Percent
-32.63103953147877
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
3.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
683000
Quarters > 0 > income Statement > cost Of Revenue
31000
Quarters > 0 > income Statement > gross Profit
652000
Quarters > 0 > income Statement > operating Expenses
38486000
Quarters > 0 > income Statement > operating Income
-37834000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-33748000
Quarters > 0 > income Statement > net Income
-33748000
Quarters > 0 > income Statement > eps
-0.6257631750053114
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
53930946
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-33717000
Quarters > 0 > income Statement > operating Margin
-5539.385065885798
Quarters > 0 > income Statement > total Other Income Expense Net
4086000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
72164000
Quarters > 0 > balance Sheet > short Term Investments
300263000
Quarters > 0 > balance Sheet > receivables
683000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
389017000
Quarters > 0 > balance Sheet > property Plant Equipment
1984000
Quarters > 0 > balance Sheet > total Assets
391195000
Quarters > 0 > balance Sheet > payables
3952000
Quarters > 0 > balance Sheet > short Term Debt
716000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
12611000
Quarters > 0 > balance Sheet > equity
378584000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-33748000
Quarters > 0 > cash Flow > depreciation
-2828000
Quarters > 0 > cash Flow > change In Working Capital
16037000
Quarters > 0 > cash Flow > cash From Operations
-22240000
Quarters > 0 > cash Flow > capital Expenditures
47000
Quarters > 0 > cash Flow > cash From Investing
48186000
Quarters > 0 > cash Flow > cash From Financing
760000
Quarters > 0 > cash Flow > net Change In Cash
26706000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6257631750053114
Quarters > 0 > ratios > PB
4.418934621959724
Quarters > 0 > ratios > ROE
-8.914270016693786
Quarters > 0 > ratios > ROA
-8.62689962806273
Quarters > 0 > ratios > FCF
-22287000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-32.63103953147877
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
937000
Quarters > 1 > income Statement > cost Of Revenue
57000
Quarters > 1 > income Statement > gross Profit
937000
Quarters > 1 > income Statement > operating Expenses
45284000
Quarters > 1 > income Statement > operating Income
-44347000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-39966000
Quarters > 1 > income Statement > net Income
-39966000
Quarters > 1 > income Statement > eps
-0.7432649218160287
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
53770868
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-44305000
Quarters > 1 > income Statement > operating Margin
-4732.870864461046
Quarters > 1 > income Statement > total Other Income Expense Net
4381000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
45458000
Quarters > 1 > balance Sheet > short Term Investments
348123000
Quarters > 1 > balance Sheet > receivables
2644000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
418272000
Quarters > 1 > balance Sheet > property Plant Equipment
2055000
Quarters > 1 > balance Sheet > total Assets
420521000
Quarters > 1 > balance Sheet > payables
2551000
Quarters > 1 > balance Sheet > short Term Debt
712000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
11778000
Quarters > 1 > balance Sheet > equity
408743000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-39966000
Quarters > 1 > cash Flow > depreciation
42000
Quarters > 1 > cash Flow > change In Working Capital
-1065000
Quarters > 1 > cash Flow > cash From Operations
-39239000
Quarters > 1 > cash Flow > capital Expenditures
47000
Quarters > 1 > cash Flow > cash From Investing
12773000
Quarters > 1 > cash Flow > cash From Financing
612000
Quarters > 1 > cash Flow > net Change In Cash
-25854000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.7432649218160287
Quarters > 1 > ratios > PB
4.080736123578875
Quarters > 1 > ratios > ROE
-9.777782127155694
Quarters > 1 > ratios > ROA
-9.503924893168236
Quarters > 1 > ratios > FCF
-39286000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-41.92742796157951
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
566000
Quarters > 2 > income Statement > cost Of Revenue
43000
Quarters > 2 > income Statement > gross Profit
566000
Quarters > 2 > income Statement > operating Expenses
32579000
Quarters > 2 > income Statement > operating Income
-32013000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-27270000
Quarters > 2 > income Statement > net Income
-27270000
Quarters > 2 > income Statement > eps
-0.5086004864473637
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
53617723
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-31970000
Quarters > 2 > income Statement > operating Margin
-5656.007067137809
Quarters > 2 > income Statement > total Other Income Expense Net
4743000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
71312000
Quarters > 2 > balance Sheet > short Term Investments
360068000
Quarters > 2 > balance Sheet > receivables
1738000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
453787000
Quarters > 2 > balance Sheet > property Plant Equipment
2188000
Quarters > 2 > balance Sheet > total Assets
456169000
Quarters > 2 > balance Sheet > payables
4718000
Quarters > 2 > balance Sheet > short Term Debt
708000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
10559000
Quarters > 2 > balance Sheet > equity
445610000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-27270000
Quarters > 2 > cash Flow > depreciation
43000
Quarters > 2 > cash Flow > change In Working Capital
-14972000
Quarters > 2 > cash Flow > cash From Operations
-41165000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-213381000
Quarters > 2 > cash Flow > cash From Financing
-34000
Quarters > 2 > cash Flow > net Change In Cash
-254580000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.5086004864473637
Quarters > 2 > ratios > PB
3.7324605988644777
Quarters > 2 > ratios > ROE
-6.119701083907453
Quarters > 2 > ratios > ROA
-5.978047609548216
Quarters > 2 > ratios > FCF
-41165000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-72.72968197879858
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
613000
Quarters > 3 > income Statement > cost Of Revenue
49000
Quarters > 3 > income Statement > gross Profit
613000
Quarters > 3 > income Statement > operating Expenses
26931000
Quarters > 3 > income Statement > operating Income
-26318000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-21242000
Quarters > 3 > income Statement > net Income
-21242000
Quarters > 3 > income Statement > eps
-0.4137378012159513
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
51341695
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-26269000
Quarters > 3 > income Statement > operating Margin
-4293.311582381729
Quarters > 3 > income Statement > total Other Income Expense Net
5076000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
325892000
Quarters > 3 > balance Sheet > short Term Investments
144559000
Quarters > 3 > balance Sheet > receivables
1180000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
479160000
Quarters > 3 > balance Sheet > property Plant Equipment
2365000
Quarters > 3 > balance Sheet > total Assets
481719000
Quarters > 3 > balance Sheet > payables
4041000
Quarters > 3 > balance Sheet > short Term Debt
704000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
11867000
Quarters > 3 > balance Sheet > equity
469852000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-21242000
Quarters > 3 > cash Flow > depreciation
49000
Quarters > 3 > cash Flow > change In Working Capital
-1318000
Quarters > 3 > cash Flow > cash From Operations
-19612000
Quarters > 3 > cash Flow > capital Expenditures
185000
Quarters > 3 > cash Flow > cash From Investing
41908000
Quarters > 3 > cash Flow > cash From Financing
270648000
Quarters > 3 > cash Flow > net Change In Cash
292944000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.4137378012159513
Quarters > 3 > ratios > PB
3.389619239462639
Quarters > 3 > ratios > ROE
-4.520998101529843
Quarters > 3 > ratios > ROA
-4.40962469821618
Quarters > 3 > ratios > FCF
-19797000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-32.2952691680261
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2370000
Annuals > 0 > income Statement > cost Of Revenue
89000
Annuals > 0 > income Statement > gross Profit
2370000
Annuals > 0 > income Statement > operating Expenses
80134000
Annuals > 0 > income Statement > operating Income
-77764000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-62806000
Annuals > 0 > income Statement > net Income
-62806000
Annuals > 0 > income Statement > eps
-1.2232942445706165
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
51341695
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-77675000
Annuals > 0 > income Statement > operating Margin
-3281.1814345991565
Annuals > 0 > income Statement > total Other Income Expense Net
14958000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
325892000
Annuals > 0 > balance Sheet > short Term Investments
144559000
Annuals > 0 > balance Sheet > receivables
1180000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
479160000
Annuals > 0 > balance Sheet > property Plant Equipment
2365000
Annuals > 0 > balance Sheet > total Assets
481719000
Annuals > 0 > balance Sheet > payables
4041000
Annuals > 0 > balance Sheet > short Term Debt
704000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
11867000
Annuals > 0 > balance Sheet > equity
469852000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-62806000
Annuals > 0 > cash Flow > depreciation
89000
Annuals > 0 > cash Flow > change In Working Capital
1873000
Annuals > 0 > cash Flow > cash From Operations
-59172000
Annuals > 0 > cash Flow > capital Expenditures
511000
Annuals > 0 > cash Flow > cash From Investing
-59485000
Annuals > 0 > cash Flow > cash From Financing
418910000
Annuals > 0 > cash Flow > net Change In Cash
300253000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.2232942445706165
Annuals > 0 > ratios > PB
2.826868140712395
Annuals > 0 > ratios > ROE
-13.367187965572139
Annuals > 0 > ratios > ROA
-13.037891384811479
Annuals > 0 > ratios > FCF
-59683000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-25.18270042194093
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2380000
Annuals > 1 > income Statement > cost Of Revenue
60000
Annuals > 1 > income Statement > gross Profit
2380000
Annuals > 1 > income Statement > operating Expenses
42494000
Annuals > 1 > income Statement > operating Income
-40114000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-20537000
Annuals > 1 > income Statement > net Income
-20537000
Annuals > 1 > income Statement > eps
-0.5653943215876566
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
36323322
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-40054000
Annuals > 1 > income Statement > operating Margin
-1685.4621848739494
Annuals > 1 > income Statement > total Other Income Expense Net
19577000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
25833000
Annuals > 1 > balance Sheet > short Term Investments
83977000
Annuals > 1 > balance Sheet > receivables
236000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
116996000
Annuals > 1 > balance Sheet > property Plant Equipment
202000
Annuals > 1 > balance Sheet > total Assets
117198000
Annuals > 1 > balance Sheet > payables
1990000
Annuals > 1 > balance Sheet > short Term Debt
45000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
240324000
Annuals > 1 > balance Sheet > equity
-123126000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-20537000
Annuals > 1 > cash Flow > depreciation
60000
Annuals > 1 > cash Flow > change In Working Capital
-4305000
Annuals > 1 > cash Flow > cash From Operations
-37926000
Annuals > 1 > cash Flow > capital Expenditures
144000
Annuals > 1 > cash Flow > cash From Investing
-82842000
Annuals > 1 > cash Flow > cash From Financing
129550000
Annuals > 1 > cash Flow > net Change In Cash
8782000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.5653943215876566
Annuals > 1 > ratios > PB
-7.631892046683885
Annuals > 1 > ratios > ROE
16.679661484982862
Annuals > 1 > ratios > ROA
-17.523336575709482
Annuals > 1 > ratios > FCF
-38070000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-15.995798319327731
Annuals > 1 > health Score
28
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1212000
Annuals > 2 > income Statement > cost Of Revenue
7000
Annuals > 2 > income Statement > gross Profit
1212000
Annuals > 2 > income Statement > operating Expenses
25121000
Annuals > 2 > income Statement > operating Income
-23909000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-23868000
Annuals > 2 > income Statement > net Income
-23868000
Annuals > 2 > income Statement > eps
-0.6570984889542867
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
36323322
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-23902000
Annuals > 2 > income Statement > operating Margin
-1972.6897689768975
Annuals > 2 > income Statement > total Other Income Expense Net
41000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
17051000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
412000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
18307000
Annuals > 2 > balance Sheet > property Plant Equipment
164000
Annuals > 2 > balance Sheet > total Assets
18478000
Annuals > 2 > balance Sheet > payables
712000
Annuals > 2 > balance Sheet > short Term Debt
87000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
124633000
Annuals > 2 > balance Sheet > equity
-106155000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-23868000
Annuals > 2 > cash Flow > depreciation
7000
Annuals > 2 > cash Flow > change In Working Capital
3412000
Annuals > 2 > cash Flow > cash From Operations
-19021000
Annuals > 2 > cash Flow > capital Expenditures
82000
Annuals > 2 > cash Flow > cash From Investing
-82000
Annuals > 2 > cash Flow > cash From Financing
9963000
Annuals > 2 > cash Flow > net Change In Cash
-9140000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.6570984889542867
Annuals > 2 > ratios > PB
-8.852002638971316
Annuals > 2 > ratios > ROE
22.48410343365833
Annuals > 2 > ratios > ROA
-129.16982357397987
Annuals > 2 > ratios > FCF
-19103000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-15.761551155115512
Annuals > 2 > health Score
30
Valuation > metrics > PE
-0.6257631750053114
Valuation > metrics > PB
4.418934621959724
Valuation > final Score
35.81065378040276
Valuation > verdict
47.3% Overvalued
Profitability > metrics > ROE
-8.914270016693786
Profitability > metrics > ROA
-8.675199284350041
Profitability > metrics > Net Margin
-49.411420204978036
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.03331096929611394
Risk > metrics > Interest Coverage
-1220.4516129032259
Risk > final Score
-4822
Risk > verdict
High
Liquidity > metrics > Current Ratio
83.33697514995715
Liquidity > metrics > Quick Ratio
83.33697514995715
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
39.19263876421125
Prev Valuations > 1
42.67539401135522
Prev Valuations > 2
46.10380760537361
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
19
Prev Risks > 1
33
Prev Risks > 2
39
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:45:33.098Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-11
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.7
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-05
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.63
Earnings History > 1 > eps Estimate
-0.78
Earnings History > 1 > eps Difference
0.15
Earnings History > 1 > surprise Percent
19.2308
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.74
Earnings History > 2 > eps Estimate
-0.61
Earnings History > 2 > eps Difference
-0.13
Earnings History > 2 > surprise Percent
-21.3115
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.51
Earnings History > 3 > eps Estimate
-0.48
Earnings History > 3 > eps Difference
-0.03
Earnings History > 3 > surprise Percent
-6.25
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-12
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.41
Earnings History > 4 > eps Estimate
-0.5403
Earnings History > 4 > eps Difference
0.1303
Earnings History > 4 > surprise Percent
24.1162
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-6.96
Earnings History > 5 > eps Estimate
-3.65
Earnings History > 5 > eps Difference
-3.31
Earnings History > 5 > surprise Percent
-90.6849
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-11.18
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-11.18
Earnings History > 6 > surprise Percent
-
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders. It offers verekitug, which is in Phase 2 clinical development for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps, and in Phase I clinical trial for treating chronic obstructive pulmonary disease. The company was incorporated in 2021 and is headquartered in Waltham, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AJ.P. Morgan Maintains UpStream Bio(UPB.US) With Buy Rating, Announces Target Price $35 富途资讯
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$49.75
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Upstream Bio, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.7
Date
2025-09-30
EPS Actual
-0.63
EPS Estimate
-0.78
EPS Difference
0.15
Surprise Percent
19.2308%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.